P

Inventor

MAEDA ATSUHIKO

JP37 patents
⚠️ This page may combine multiple inventors who share the name “MAEDA ATSUHIKO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CHUGAI PHARMACEUTICAL CO LTD

20 patents
US9890377B2Feb 13, 2018

Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly

CHUGAI PHARMACEUTICAL CO LTD34 citations98
US9969800B2May 15, 2018

IL-8 antibodies

CHUGAI PHARMACEUTICAL CO LTD37 citations96
US10662245B2May 26, 2020

Methods of reducing IL-6 activity for disease treatment

CHUGAI PHARMACEUTICAL CO LTD22 citations94
US10472623B2Nov 12, 2019

Antigen-binding molecule capable of binding two or more antigen molecules repeatedly

CHUGAI PHARMACEUTICAL CO LTD29 citations94
US10253091B2Apr 9, 2019

Antibody constant region variant

CHUGAI PHARMACEUTICAL CO LTD27 citations94
US10253100B2Apr 9, 2019

Therapeutic antigen-binding molecule with a FcRn-binding domain that promotes antigen clearance

CHUGAI PHARMACEUTICAL CO LTD37 citations94
US10066018B2Sep 4, 2018

Antibody constant region variant

CHUGAI PHARMACEUTICAL CO LTD28 citations94
US9868948B2Jan 16, 2018

Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly

CHUGAI PHARMACEUTICAL CO LTD27 citations94
US10519229B2Dec 31, 2019

Nucleic acids encoding IL-8 antibodies

CHUGAI PHARMACEUTICAL CO LTD22 citations93
US11718678B2Aug 8, 2023

Method for altering plasma retention and immunogenicity of antigen-binding molecule

CHUGAI PHARMACEUTICAL CO LTD7 citations85
US11827699B2Nov 28, 2023

Methods for producing antibodies promoting disappearance of antigens having plurality of biological activities

CHUGAI PHARMACEUTICAL CO LTD8 citations84
US11371039B2Jun 28, 2022

Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly

CHUGAI PHARMACEUTICAL CO LTD4 citations84
US11359194B2Jun 14, 2022

Antigen-binding molecule capable of binding two or more antigen molecules repeatedly

CHUGAI PHARMACEUTICAL CO LTD4 citations84
US11180548B2Nov 23, 2021

Methods of neutralizing IL-8 biological activity

CHUGAI PHARMACEUTICAL CO LTD6 citations83
US10556949B2Feb 11, 2020

Antigen-binding molecule inducing immune response to target antigen

CHUGAI PHARMACEUTICAL CO LTD8 citations83
US11891434B2Feb 6, 2024

Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly

CHUGAI PHARMACEUTICAL CO LTD6 citations73
US9556264B2Jan 31, 2017

Humanized anti-epiregulin antibody, and cancer therapeutic agent comprising said antibody as active ingredient

CHUGAI PHARMACEUTICAL CO LTD5 citations70
US12371485B2Jul 29, 2025

Antigen-binding molecule inducing immune response to target antigen

CHUGAI PHARMACEUTICAL CO LTD0 citations62
US12269876B2Apr 8, 2025

Modified Fc region of antibody

CHUGAI PHARMACEUTICAL CO LTD0 citations51
US11059881B2Jul 13, 2021

Method for measuring viscosity of protein solution

CHUGAI PHARMACEUTICAL CO LTD0 citations47

NIPPON TELEGRAPH & TELEPHONE

8 patents

IGAWA TOMOYUKI

3 patents

KURAMOCHI TAICHI

2 patents

MAEDA ATSUHIKO

2 patents

NAT INST ADVANCED IND SCIENCE & TECH

1 patent

CHUGAI SEIYAKU KK

1 patent